Requirement for p38 and p44/p42 Mitogen-Activated Protein Kinases in RAGE-Mediated Nuclear Factor-κB Transcriptional Activation and Cytokine Secretion
- Chen-Hsiung Yeh1,
- Lydia Sturgis1,
- Joe Haidacher1,
- Xue-Nong Zhang1,
- Sidney J. Sherwood1,
- Robert J. Bjercke2,
- Ondrej Juhasz3,
- Michael T. Crow3,
- Ronald G. Tilton1 and
- Larry Denner1
- 1Cell Biology and Apoptosis Program and the
- 2Department of Immunology, Texas Biotechnology Corporation, Houston, Texas
- 3Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland
Abstract
Advanced glycation end product (AGE) activation of the signal-transducing receptor for AGE (RAGE) has been linked to a proinflammatory phenotypic change within cells. However, the precise intracellular signaling pathways involved have not been elucidated. We demonstrate here that human serum albumin modified with Nε-(carboxymethyl)lysine (CML), a major AGE adduct that progressively accumulates with aging, diabetes, and renal failure, induced nuclear factor (NF)-κB–driven reporter gene expression in human monocytic THP-1 cells. The NF-κB response was blocked with a synthetic peptide corresponding to the putative ligand-binding domain of RAGE, with anti-RAGE antiserum, and by coexpression of truncated receptors lacking the intracellular domain. Signal transduction from RAGE to NF-κB involved the generation of reactive oxygen species, since reporter gene expression was blocked with the antioxidant N-acetyl-l-cysteine. CML-modified albumin produced rapid transient activation of tyrosine phosphorylation, extracellular signal-regulated kinase 1 and 2, and p38 mitogen-activated protein kinase (MAPK), but not c-Jun NH2-terminal kinase. RAGE-mediated NF-κB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant. Activation of NF-κB by CML-modified albumin increased secretion of proinflammatory cytokines (tumor necrosis factor-α, interleukin-1β, and monocyte chemoattractant protein-1) severalfold, and inhibition of p38 MAPK blocked these increases. These results indicate that p38 MAPK activation mediates RAGE-induced NF-κB–dependent secretion of proinflammatory cytokines and suggest that accelerated inflammation may be a consequence of cellular activation induced by this receptor.
Footnotes
-
Address correspondence and reprint requests to Dr. Larry Denner, PhD, Department of Cell Biology, Texas Biotechnology Corporation, 7000 Fannin, Houston, TX 77030. E-mail: ldenner{at}tbc.com.
Received for publication 7 July 2000 and accepted in revised form 15 March 2001.
C.-H.Y., L.S., J.H., X.-N.Z., S.J.S., R.J.B., R.G.T., and L.D. are stock shareholders.
CML-HSA, Nε-(carboxymethyl)lysine; DTT, dithiothreitol; ELISA, enzyme-linked immunosorbent assay; ERK, extracellular signal-regulated kinase; HSA, human serum albumin; ΙL, interleukin; JNK, c-Jun NH2-terminal kinase; MAPK, mitogen-activated protein kinase; MCP, monocyte chemoattractant protein; NAC, N-acetyl-l-cysteine; NF, nuclear factor; PCR, polymerase chain reaction; PMSF, phenylmethylsulfonyl fluoride; PTK, protein tyrosine kinase; RAGE, receptor for AGE; RT, reverse transcriptase; SFM, serum-free medium; TNF, tumor necrosis factor.














